Clinical Trial · NCT06463782

Phase I Clinical Trial of the Safety, Pharmacokinetics, Biodistribution and Dosimetry of 68Ga-LNC1007 Injection in Adult Healthy Volunteers and Solid Tumor Patients

Overview

This study is a single-arm, single-center trial aimed at evaluating the safety, pharmacokinetics, biodistribution and dosimetry of 68Ga-LNC1007 Injection in adult healthy volunteers and solid tumor patients.

Sponsor

Yantai LNC Biotechnology Singapore PTE LTD

Phase

Phase 1

Contacts

Professor Khong Pek-Lan

65 65167408

ClinicalTrials.gov

NCT06463782